Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Disodium pamidronate pentahydrate

Disodium pamidronate pentahydrate

pharmaceutical raw materials
Disodium pamidronate pentahydrate structure

Disodium pamidronate pentahydrate 

structure
  • CAS No:

    109552-15-0

  • Formula:

    C3H11NO7P2.5H2O.2Na

  • Chemical Name:

    Disodium pamidronate pentahydrate

  • Synonyms:

    Phosphonic acid,P,P′-(3-amino-1-hydroxypropylidene)bis-,sodium salt,hydrate (1:2:5);Phosphonic acid,(3-amino-1-hydroxypropylidene)bis-,disodium salt,pentahydrate;Disodium pamidronate pentahydrate

  • Categories:

    Organic Chemistry  >  Phosphines

Description

Pamidronate disodium pentahydrate is a nitrogen-containing bisphosphonate, used to prevent osteoporosis.


Pamidronate disodium is a 1,1-bis(phosphonic acid).|Pamidronate Disodium is the disodium salt of the synthetic bisphosphonate pamidronate. Although its mechanism of action is not completely understood, pamidronate appears to adsorb to calcium phosphate crystals in bone, blocking their dissolution by inhibiting osteoclast-mediated bone resorption. This agent does not inhibit bone mineralization and formation.|An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies.

Disodium pamidronate pentahydrate Basic Attributes

279.03

369.01778760 g/mol

260-647-1

8742T8ZQZA

DTXSID5042667

C1345

2942000000

Characteristics

232.74000

658.7ºC at 760 mmHg

352.2ºC

2-8°C

Safety Information

NONH for all modes of transport

SZ6522666

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P260, P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P309+P311, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 5 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|P264, P270, P301+P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Drug: Pamidronatedisodium

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)

(3-amino-1-hydroxypropylidene)-1,1-biphosphonate

Disodium pamidronate pentahydrate Use and Manufacturing

Uses

For the treatment of hypercalcemia and osteoporosis

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:369.11
Hydrogen Bond Donor Count:9
Hydrogen Bond Acceptor Count:13
Rotatable Bond Count:4
Exact Mass:369.01778760
Monoisotopic Mass:369.01778760
Topological Polar Surface Area:172
Heavy Atom Count:20
Complexity:238
Covalently-Bonded Unit Count:8
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Unspecified

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Luzhou Kereide Pharmaceutical Co., Ltd.

    China China
    Active
  • Jiangsu Shenlong Pharmaceutical Co., Ltd.

    China China
    Active
  • Hebei Anjian Chengyi Pharmaceutical Technology Co., Ltd.

    China China
    Active

Recommended Suppliers of Disodium pamidronate pentahydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.